- Home
- MDAI vs JSPR Comparison
MDAI vs JSPR Comparison
Compare MDAI & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDAI
- JSPR
- Stock Information
- Founded
- MDAI 2013
- JSPR 2018
- Country
- MDAI United States
- JSPR United States
- Employees
- MDAI N/A
- JSPR N/A
- Industry
- MDAI Medical/Dental Instruments
- JSPR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MDAI Health Care
- JSPR Health Care
- Exchange
- MDAI Nasdaq
- JSPR Nasdaq
- Market Cap
- MDAI 51.9M
- JSPR 47.6M
- IPO Year
- MDAI N/A
- JSPR N/A
- Fundamental
- Price
- MDAI $2.45
- JSPR $2.50
- Analyst Decision
- MDAI Strong Buy
- JSPR Buy
- Analyst Count
- MDAI 1
- JSPR 11
- Target Price
- MDAI $3.50
- JSPR $28.00
- AVG Volume (30 Days)
- MDAI 603.2K
- JSPR 460.5K
- Earning Date
- MDAI 11-05-2025
- JSPR 11-06-2025
- Dividend Yield
- MDAI N/A
- JSPR N/A
- EPS Growth
- MDAI N/A
- JSPR N/A
- EPS
- MDAI N/A
- JSPR N/A
- Revenue
- MDAI $27,549,000.00
- JSPR N/A
- Revenue This Year
- MDAI N/A
- JSPR N/A
- Revenue Next Year
- MDAI $60.05
- JSPR N/A
- P/E Ratio
- MDAI N/A
- JSPR N/A
- Revenue Growth
- MDAI 22.27
- JSPR N/A
- 52 Week Low
- MDAI $1.01
- JSPR $2.22
- 52 Week High
- MDAI $3.25
- JSPR $26.05
- Technical
- Relative Strength Index (RSI)
- MDAI 59.37
- JSPR 46.41
- Support Level
- MDAI $2.21
- JSPR $2.29
- Resistance Level
- MDAI $2.57
- JSPR $2.53
- Average True Range (ATR)
- MDAI 0.17
- JSPR 0.17
- MACD
- MDAI 0.03
- JSPR 0.03
- Stochastic Oscillator
- MDAI 75.75
- JSPR 78.87
About MDAI Spectral AI Inc.
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.